Bio-Rad Laboratories | BIO - Selling And Administration Expenses


Bio-Rad Laboratories reported $207.7M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 428M 37M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Bio Techne USD 116.21M 80.43M Sep/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Bruker USD 242.5M 11.1M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 256M 59M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
Merck USD 2.63B 0 Sep/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Quest Diagnostics USD 501M 15M Sep/2025
Repligen USD 73.66M 2.43M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 4.1B 526M Sep/2025
Standard Biotools USD 26.6M 1.5M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Tosoh JPY 38.9B 1.69B Sep/2025
Waters USD 214.23M 12.97M Sep/2025